MOBILion Systems
PrivateLast Round
Series C
Jul 13, 2021
Total Funding Raised
$114.8M
Company Overview
MOBILion Systems operates in Healthcare & Life Sciences and is based in Pennsylvania. Its latest recorded funding round was a Series C round in July 2021.
MOBILion Systems is a biotechnology company that develops advanced analytical instrumentation devices to enhance disease prediction, diagnosis, and treatment through rapid and sensitive detection of clinically relevant molecules.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MOBILion Systems Comparables
Compare MOBILion Systems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bruker | 79% | |
| Excellims Corporation | 76% | |
| Thermo Fisher Scientific Inc. | 75% |
For institutional investors. Book with your work email.
MOBILion Systems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 13, 2021 | ||||
| Grant | Nov 10, 2020 | ||||
| Series B | Aug 17, 2020 | ||||
| Debt | Apr 15, 2020 | ||||
| Series A | Nov 12, 2019 | ||||
Seed | Apr 11, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MOBILion Systems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| iSelect Fund | Series A |
| IP Group | Series A, Series C, Series B |
| Hostplus Superannuation Fund | Series A, Series C, Series B |
| Shake it Up Australia Foundation | Grant |
| Cultivation Capital | Series A, Series C, Series B |
| D1 Capital Partners | Series C |
| aMoon | Series C, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Monthly visitors increased 50% MoM, reaching 2.9K.
- May 27, 2025
Next-generation proteomics platform to be revealed at ASMS 2025.
For institutional investors. Book with your work email.
MOBILion Systems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MOBILion Systems's valuation, stock price, and market status.
Is MOBILion Systems a public or private company?
MOBILion Systems is a private company.
What is the current stock price of MOBILion Systems?
MOBILion Systems is a private company, so its shares have no public market price. Caplight tracks MOBILion Systems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MOBILion Systems worth (valuation)?
Valuation information for MOBILion Systems is not publicly available.
Can I buy MOBILion Systems stock?
MOBILion Systems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MOBILion Systems's last funding round?
MOBILion Systems's most recent funding round was Series C on July 13, 2021.
Who are the main investors in MOBILion Systems?
Key investors in MOBILion Systems include D1 Capital Partners, aMoon.
Will MOBILion Systems IPO soon?
No public IPO plans have been announced for MOBILion Systems.
How can I track MOBILion Systems secondary market activity?
Caplight tracks bids, offers, and trades in MOBILion Systems's shares on secondary markets.